Relafen 750, chemically known as naproxen, represents a significant case study from a biochemical pharmacy standpoint. This exhibits its medicinal effect primarily by blocking the activity of cyclooxygenase (COX) enzymes, specifically COX-2, thereby suppressing prostaglandin formation. The targeted inhibition of COX-2, compared to traditional NSAID